Whole blood storage time impairs clot strength with minimal change in functional fibrinogen concentration

Documenti analoghi

• Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?
  di: Nadia M. Keltner, et al.
  Pubblicazione: (2024)
• Platelet clotting defects in severe trauma identified by a whole blood microfluidic assay
  di: Gian Rivera Crespo, et al.
  Pubblicazione: (2026)
• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  di: Aaron S. Hess, et al.
  Pubblicazione: (2026)
• On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray
  di: Matej Zrimsek, et al.
  Pubblicazione: (2025)
• Donors with repeated blood product discards for filtration problems, clots or hemolysis: Causes and follow‐up
  di: Niubel Díaz Padilla, et al.
  Pubblicazione: (2024)